Matthew Yeowart
Lawyers
Filters
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
bit.bio $50 million Series C equity financing
We are advising the company on the funding round
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction
Semrush Holdings $1.9 billion sale to Adobe
We are advising Semrush on the transaction
Sibanye-Stillwater $105 million acquisition of Metallix
We are advising Sibanye-Stillwater on the acquisition
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
CoreWeave acquisition of Monolith AI
We are advising CoreWeave on the transaction
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale